These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16556692)

  • 1. Pulmonary biomarkers in chronic obstructive pulmonary disease.
    Barnes PJ; Chowdhury B; Kharitonov SA; Magnussen H; Page CP; Postma D; Saetta M
    Am J Respir Crit Care Med; 2006 Jul; 174(1):6-14. PubMed ID: 16556692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in COPD.
    Cazzola M; Novelli G
    Pulm Pharmacol Ther; 2010 Dec; 23(6):493-500. PubMed ID: 20471487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Airway biomarkers in chronic obstructive pulmonary disease].
    Tohda Y; Higashimoto Y
    Nihon Rinsho; 2011 Oct; 69(10):1802-5. PubMed ID: 22073577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
    Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled breath condensate analysis in chronic obstructive pulmonary disease.
    Chhabra SK; Gupta M
    Indian J Chest Dis Allied Sci; 2012; 54(1):27-37. PubMed ID: 22779120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of airway inflammation in chronic obstructive pulmonary disease: biomarkers in exhaled breath condensate].
    Antus B
    Orv Hetil; 2012 Jun; 153(22):843-51. PubMed ID: 22641258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in COPD.
    Tzortzaki EG; Lambiri I; Vlachaki E; Siafakas NM
    Curr Med Chem; 2007; 14(9):1037-48. PubMed ID: 17439401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical utility of biomarkers in asthma and COPD.
    Snell N; Newbold P
    Curr Opin Pharmacol; 2008 Jun; 8(3):222-35. PubMed ID: 18468485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory markers for COPD in "susceptible" smokers.
    Tzortzaki EG; Tsoumakidou M; Makris D; Siafakas NM
    Clin Chim Acta; 2006 Feb; 364(1-2):124-38. PubMed ID: 16139829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breath condensate nitrite correlates with hyperinflation in chronic obstructive pulmonary disease.
    Gessner C; Hammerschmidt S; Kuhn H; Hoheisel G; Gillissen A; Sack U; Wirtz H
    Respir Med; 2007 Nov; 101(11):2271-8. PubMed ID: 17693071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Examination of exhaled breath condensate in patients with asthma and chronic obstructive pulmonary diseases].
    Cáp P; Pehal F
    Cas Lek Cesk; 2004; 143(11):742-6; discussion 746-7. PubMed ID: 15628568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics-based biomarkers in chronic obstructive pulmonary disease.
    Chen H; Wang D; Bai C; Wang X
    J Proteome Res; 2010 Jun; 9(6):2798-808. PubMed ID: 20387909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in proteomic techniques for biomarker discovery in COPD.
    Casado B; Luisetti M; Iadarola P
    Expert Rev Clin Immunol; 2011 Jan; 7(1):111-23. PubMed ID: 21162654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics and condition of the bronchial tree in patients with bronchial asthma and chronic obstructive pulmonary disease in combination with hyperoxaluria].
    Fedoseev GB; Petrova MA; Shaĭlieva LO; Kakliugin AP; Zorina ML; Sakharov AN; Pavliukova NO
    Ter Arkh; 2007; 79(3):37-41. PubMed ID: 17526194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum.
    Röpcke S; Holz O; Lauer G; Müller M; Rittinghausen S; Ernst P; Lahu G; Elmlinger M; Krug N; Hohlfeld JM
    PLoS One; 2012; 7(10):e46207. PubMed ID: 23056262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid metabolite levels of prostaglandin D2 and eicosapentaenoic acid recovered from bronchoalveolar lavage fluid correlate with lung function of chronic obstructive pulmonary disease patients and controls.
    Csanky E; Rühl R; Scholtz B; Vasko A; Takacs L; Hempel WM
    Electrophoresis; 2009 Apr; 30(7):1228-34. PubMed ID: 19294692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease.
    Kharitonov SA; Barnes PJ
    Proc Am Thorac Soc; 2004; 1(3):191-9. PubMed ID: 16113434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers.
    Mazur W; Stark H; Sovijärvi A; Myllärniemi M; Kinnula VL
    Respiration; 2009; 78(2):209-16. PubMed ID: 19252398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in chronic obstructive pulmonary disease.
    Sin DD; Vestbo J
    Proc Am Thorac Soc; 2009 Sep; 6(6):543-5. PubMed ID: 19741266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability.
    Sapey E; Bayley D; Ahmad A; Newbold P; Snell N; Stockley RA
    Thorax; 2008 Jun; 63(6):493-9. PubMed ID: 18057097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.